Show simple item record

Fasciolasis hepática humana: resistencia al tratamiento con triclabendazol

dc.contributoren-US
dc.contributorUniversidad de Chilees-ES
dc.creatorGil, Luis Carlos; Hospital Clínico Universidad de Chile
dc.creatorDíaz, Alex; Residente de Gastroenterología, Hospital clínico Universidad de Chile.
dc.creatorRueda, Carlos; Hospital Victoria IX Región.
dc.creatorMartínez, Christian
dc.creatorCastillo, Douglas
dc.creatorApt, Werner
dc.date2014-10-08
dc.date.accessioned2019-11-11T18:27:11Z
dc.date.available2019-11-11T18:27:11Z
dc.identifierhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/3549
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/111020
dc.descriptionHuman fascioliasis is a parasitic zoonosis that affects the liver of human and herbivorous animals. In chronic cases, its diagnosis is confirmed by direct visualization of parasitic eggs in stool examination, by positive testing for Fasciola hepatica antigens in stools, or by direct observation of parasites by endoscopic retrograde cholangiography or surgery. In acute cases, serological reactions as immunoblothing or detection of parasite antigens in the blood are useful. The treatment of choice is triclabendazole. However, parasite resistance in animals, as well as in man, has been reported to this drug. We report four patients in whom the parasitic infection persisted despite a course of treatment with triclabendazole.en-US
dc.descriptionHuman fascioliasis is a parasitic zoonosis that affects the liver of human and herbivorous animals. In chronic cases, its diagnosis is confirmed by direct visualization of parasitic eggs in stool examination, by positive testing for Fasciola hepatica antigens in stools, or by direct observation of parasites by endoscopic retrograde cholangiography or surgery. In acute cases, serological reactions as immunoblothing or detection of parasite antigens in the blood are useful. The treatment of choice is triclabendazole. However, parasite resistance in animals, as well as in man, has been reported to this drug. We report four patients in whom the parasitic infection persisted despite a course of treatment with triclabendazole.es-ES
dc.formatapplication/unknown
dc.languagespa
dc.publisherRevista Médica de Chilees-ES
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/3549/527
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/14976
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/14977
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/14978
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/14979
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/14980
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/14981
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/14982
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/14983
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/14984
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/14985
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/14986
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/14987
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/15154
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/3549/16329
dc.sourceRevista Médica de Chile; Vol. 142, núm. 10 (2014): OCTUBRE 2014es-ES
dc.source0034-9887
dc.subjectCholangiography; Fasciola hepatica; Triclabendazoleen-US
dc.subjectCholangiography; Fasciola hepatica; Triclabendazolees-ES
dc.titleRESISTANT HUMAN FASCIOLASIS. REPORT OF FOUR PATIENTS.en-US
dc.titleFasciolasis hepática humana: resistencia al tratamiento con triclabendazoles-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typees-ES


This item appears in the following Collection(s)

Show simple item record